Cullinan Oncology (CGEM) Reiterated at Buy by Stifel on CLN-978 Data

May 19, 2026 6:51 AM

Stifel analyst Alex Thompson reiterated a Buy rating and $28.00 price target on Cullinan Oncology Inc. (NASDAQ: CGEM).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found